ArticlePharmaceutics2022

Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host-Guest Complexes in a Comparative Evaluation.

Shohreh Peimanfard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.